Home - Triumvira Immunologics | Engineered T Cell Therapies
Empowering the body’s natural defenses against life-threatening cancers.
How we're making a difference](/#view-video)
T cell Antigen Coupler (TAC) Platform
Leveraging a T cell’s own recognition, activation and signaling properties.
Our proprietary TAC technology utilizes a novel mechanism of action (MoA) with the potential to enhance the immune response of millions of patients with difficult-to-treat tumors.
Co-opting Natural T Cell Biology
TAC enables T cells to locate and destroy tumor cells through natural activation and maximal, controlled anti-tumor responses.
Broad Applicability in Cancers
By enabling T cells to target cancer cells using different antigens, TAC may be applied across a wide range of liquid and solid tumors.
Innovative Capabilities in T cell Manufacturing
We leverage the most advanced manufacturing technologies for optimum product quality.
Learn more about T cell therapy
Pipeline & Programs
Building a robust pipeline of TAC-T cell therapies.
We are developing multiple TAC-based therapeutic candidates using both autologous and allogeneic manufacturing approaches. All programs leveraging our TAC technology have the potential for broad applicability across cancers with a high unmet need.